Literature DB >> 8449574

Vaccination of adults against travel-related infectious diseases, and new developments in vaccines.

P C Döller1.   

Abstract

The number of people travelling to tropical or subtropical countries, whether for holidays or for business, is steadily increasing. Many of these travellers are at risk of acquiring an infectious disease. Protection against certain infectious diseases is possible by vaccination. Vaccinations required or recommended for adults are reviewed here. Progress in the refinement of available vaccines, as well as the development of new vaccines, is discussed.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8449574     DOI： 10.1007/bf01739302

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


  68 in total

1.  Potential use of live viral and bacterial vectors for vaccines. WHO meeting, Geneva, 19-22 June, 1989.

Authors: 
Journal:  Vaccine       Date:  1990-10       Impact factor: 3.641

Review 2.  Peptide vaccines for viral diseases.

Authors:  M J Francis
Journal:  Sci Prog       Date:  1990       Impact factor: 2.774

Review 3.  Enteric vaccines.

Authors:  R Edelman; M M Levine
Journal:  Md Med J       Date:  1991-03

4.  Interferon-alpha and synthetic peptide malaria sporozoite vaccine in non-immune adults: antibody response after 40 weeks.

Authors:  D Stürchler; G Zimmer; R Berger; H Etlinger; M Fernex; H Matile; M Just
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

5.  Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age.

Authors:  J C Parke; R Schneerson; C Reimer; C Black; S Welfare; D Bryla; L Levi; D Pavliakova; T Cramton; D Schulz
Journal:  J Pediatr       Date:  1991-02       Impact factor: 4.406

6.  Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children.

Authors:  R W Sutter; P A Patriarca; S Brogan; P G Malankar; M A Pallansch; O M Kew; A G Bass; S L Cochi; J P Alexander; D B Hall
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

7.  Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.

Authors:  D A Herrington; D F Clyde; J R Davis; S Baqar; J R Murphy; J F Cortese; R S Bank; E Nardin; D DiJohn; R S Nussenzweig
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

Review 8.  New developments in the pre- and post-exposure treatment of rabies.

Authors:  B Dietzschold; H C Ertl
Journal:  Crit Rev Immunol       Date:  1991       Impact factor: 2.214

9.  A recombinant vaccinia virus expressing hepatitis A virus structural polypeptides: characterization and demonstration of protective immunogenicity.

Authors:  P Karayiannis; S O'Rourke; M J McGarvey; S Luther; J Waters; R Goldin; H C Thomas
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

10.  Preventing secondary infections among HIV-positive persons.

Authors:  G A Filice; C Pomeroy
Journal:  Public Health Rep       Date:  1991 Sep-Oct       Impact factor: 2.792
View more
  1 in total

1.  Hepatitis A in Western Austria--the epidemiological situation before the introduction of active immunisation.

Authors:  W M Prodinger; C Larcher; B M Sölder; D Geissler; M P Dierich
Journal:  Infection       Date:  1994 Jan-Feb       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.